CONRAD HERBERT J has filed 4 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 16500 shares of Celldex Therapeutics, Inc. ($CLDX) on June 05, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2025 | Celldex Therapeutics, Inc. | $CLDX | CONRAD HERBERT J | Not found | A | Non-Qualified Stock Option (right to buy) | 16500 | $0.00 | 16,500.0000 | 66,383 | 9999.99% | 24.86% |
| June 13, 2024 | Celldex Therapeutics, Inc. | $CLDX | CONRAD HERBERT J | Not found | A | Non-Qualified Stock Option (right to buy) | 16500 | $0.00 | 16,500.0000 | 58,871 | 9999.99% | 28.03% |
| Nov. 1, 2023 | Matinas BioPharma Holdings, Inc. | $MTNB | CONRAD HERBERT J | Director | A | Stock option (right to buy) | 437244 | $0.00 | 437,244.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Celldex Therapeutics, Inc. | $CLDX | CONRAD HERBERT J | Not found | A | Non-Qualified Stock Option (right to buy) | 11300 | $0.00 | 11,300.0000 | 47,214 | 9999.99% | 23.93% |